Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Dynamic behavior of DNA topoisomerase IIβ in response to DNA double-strand breaks.

Morotomi-Yano K, Saito S, Adachi N, Yano KI.

Sci Rep. 2018 Jul 9;8(1):10344. doi: 10.1038/s41598-018-28690-6.

2.

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells.

Hazlehurst LA, Valkov N, Wisner L, Storey JA, Boulware D, Sullivan DM, Dalton WS.

Blood. 2001 Sep 15;98(6):1897-903.

3.

The Roles of DNA Topoisomerase IIβ in Transcription.

Madabhushi R.

Int J Mol Sci. 2018 Jun 29;19(7). pii: E1917. doi: 10.3390/ijms19071917. Review.

4.

DNA Topoisomerase IIα contributes to the early steps of adipogenesis in 3T3-L1 cells.

Jacobsen RG, Mazloumi Gavgani F, Mellgren G, Lewis AE.

Cell Signal. 2016 Oct;28(10):1593-603. doi: 10.1016/j.cellsig.2016.07.002. Epub 2016 Jul 9.

6.

Human DNA-Topoisomerases - Diagnostic and Therapeutic Implications for Cancer.

Kellner U, Rudolph P, Parwaresch R.

Onkologie. 2000 Oct;23(5):424-430.

PMID:
11441236
7.

Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.

Mosesso P, Pepe G, Ottavianelli A, Schinoppi A, Cinelli S.

Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:14-8. doi: 10.1016/j.mrgentox.2015.06.006. Epub 2015 Jun 15.

PMID:
26520368
8.

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.

Kozuki T, Chikamori K, Surleac MD, Micluta MA, Petrescu AJ, Norris EJ, Elson P, Hoeltge GA, Grabowski DR, Porter ACG, Ganapathi RN, Ganapathi MK.

Nucleic Acids Res. 2017 Jun 2;45(10):5995-6010. doi: 10.1093/nar/gkx325.

9.

DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells.

Isik S, Zaim M, Yildiz MT, Negis Y, Kunduraci T, Karakas N, Arikan G, Cetin G.

Ann Hematol. 2015 Feb;94(2):307-18. doi: 10.1007/s00277-014-2209-7. Epub 2014 Sep 13.

PMID:
25217229
10.
11.

Involvement of DNA topoisomerase IIbeta in neuronal differentiation.

Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A.

J Biol Chem. 2001 Feb 23;276(8):5769-78. Epub 2000 Dec 5.

12.

Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells.

Sugimoto K, Yamada K, Egashira M, Yazaki Y, Hirai H, Kikuchi A, Oshimi K.

Blood. 1998 Feb 15;91(4):1407-17.

13.
14.

Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.

Sakaguchi A, Kikuchi A.

J Cell Sci. 2004 Mar 1;117(Pt 7):1047-54.

15.

Nuclear dynamics of topoisomerase IIβ reflects its catalytic activity that is regulated by binding of RNA to the C-terminal domain.

Onoda A, Hosoya O, Sano K, Kiyama K, Kimura H, Kawano S, Furuta R, Miyaji M, Tsutsui K, Tsutsui KM.

Nucleic Acids Res. 2014 Aug;42(14):9005-20. doi: 10.1093/nar/gku640. Epub 2014 Jul 17.

16.

Cellular Model of Alzheimer's Disease: Aβ1-42 Peptide Induces Amyloid Deposition and a Decrease in Topo Isomerase IIβ and Nurr1 Expression.

Terzioglu-Usak S, Negis Y, Karabulut DS, Zaim M, Isik S.

Curr Alzheimer Res. 2017;14(6):636-644. doi: 10.2174/1567205014666170117103217.

PMID:
28124588
17.

Prognostic values of filamin-A status for topoisomerase II poison chemotherapy.

Yue J, Lan S, Yuan C, Shen Z.

Int J Biol Sci. 2012;8(4):442-50. doi: 10.7150/ijbs.4155. Epub 2012 Feb 29.

19.

Tirapazamine: a hypoxia-activated topoisomerase II poison.

Peters KB, Brown JM.

Cancer Res. 2002 Sep 15;62(18):5248-53.

20.

Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes.

Madabhushi R, Gao F, Pfenning AR, Pan L, Yamakawa S, Seo J, Rueda R, Phan TX, Yamakawa H, Pao PC, Stott RT, Gjoneska E, Nott A, Cho S, Kellis M, Tsai LH.

Cell. 2015 Jun 18;161(7):1592-605. doi: 10.1016/j.cell.2015.05.032. Epub 2015 Jun 4.

Supplemental Content

Support Center